BullishAgent BullishAgent Filings Market Economic Earnings Ratings Gaps IPOs ETFs Insiders Institutional Funds Screener
Sign in Register

BIAF

bioAffinity Technologies, Inc. NASDAQ Listed Sep 1, 2022
Healthcare ·Medical - Diagnostics & Research ·US · bioaffinitytech.com
$2.12
Mkt Cap $9.5M
52w Low $0.69 10.0% of range 52w High $15.00
50d MA $2.56 200d MA $3.38
P/E (TTM) -0.2x
EV/EBITDA 0.3x
P/B 0.5x
Debt/Equity 0.2x
ROE -204.9%
P/FCF -0.2x
RSI (14)
ATR (14)
Beta -0.81
50d MA $2.56
200d MA $3.38
Avg Volume 8.9M
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
SIC Code
8731
CIK (SEC)
Phone
210 698 5334
22211 West Interstate 10 · San Antonio, TX 78257 · US
Data updated apr 24, 2026 9:37pm · Source: massive.com